NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
Wen Zhou(Academy of Medical Sciences), Fenghuang Zhan(Winthrop Rockefeller Foundation), Rodney R. Miles(Inserm), Shashirekha Shetty(Cleveland Clinic), Ye Yang(Yangtze University), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), David J. Bearss(Unknown), Tiehua Chen(University of Utah), Guido Tricot, Zhaoyang Zeng(Shenzhen Academy of Robotics), Jiliang Xia(Central South University), Maurizio Zangari(University of Arkansas for Medical Sciences), He Wang(Nanjing Agricultural University), Wei Xiong(Hainan Medical University), Hongwei Xu(Minzu University of China), Lei Shi(Sun Yat-sen University)
Cited by 302
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718